HOME › DRUGS › COVID-19 VACCINE (CHADOX1-S [RECOMBINANT])
ACTIVE SUBSTANCE / INN

COVID-19 VACCINE (CHADOX1-S [RECOMBINANT])

Brand name(s): Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
EMA LISTED
WITHDRAWN
COVID-19 virus infection
ACTIVE SUBSTANCE
Covid-19 Vaccine (Chadox1-S [Recombinant])
REGULATORS
EMA
SPONSORS / MAH
AstraZeneca AB
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)AstraZeneca ABWithdrawn29/01/2021COVID-19 virus infection

FULL INTELLIGENCE ON COVID-19 VACCINE (CHADOX1-S [RECOMBINANT])

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →